Opana ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Endo Pharmaceuticals, Inc.. The primary component is Oxymorphone Hydrochloride.
Product ID | 63481-817_78824d02-9c7b-45ce-8030-48bc1d817cc6 |
NDC | 63481-817 |
Product Type | Human Prescription Drug |
Proprietary Name | Opana ER |
Generic Name | Oxymorphone Hydrochloride |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2012-03-20 |
Marketing End Date | 2019-11-01 |
Marketing Category | NDA / NDA |
Application Number | NDA201655 |
Labeler Name | Endo Pharmaceuticals, Inc. |
Substance Name | OXYMORPHONE HYDROCHLORIDE |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Marketing Start Date | 2012-03-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA201655 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-03-20 |
Marketing End Date | 2012-03-20 |
Marketing Category | NDA |
Application Number | NDA201655 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-03-20 |
Marketing End Date | 2019-11-01 |
Marketing Category | NDA |
Application Number | NDA201655 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-03-20 |
Marketing End Date | 2014-10-31 |
Ingredient | Strength |
---|---|
OXYMORPHONE HYDROCHLORIDE | 30 mg/1 |
SPL SET ID: | e6e34c18-fbc6-4cab-9aed-0905d93c2ab6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
21695-948 | OPANA ER | OPANA ER |
21695-949 | OPANA ER | OPANA ER |
35356-825 | Opana ER | Opana ER |
35356-848 | Opana ER | Opana ER |
35356-849 | Opana ER | Opana ER |
35356-820 | Opana ER | Opana ER |
63481-816 | Opana ER | Opana ER |
63481-817 | Opana ER | Opana ER |
63481-814 | Opana ER | Opana ER |
63481-815 | Opana ER | Opana ER |
63481-818 | Opana ER | Opana ER |
63481-812 | Opana ER | Opana ER |
63481-813 | Opana ER | Opana ER |
63629-4174 | Opana ER | Opana ER |
63629-4177 | OPANA ER | OPANA ER |
0054-0283 | Oxymorphone Hydrochloride | oxymorphone hydrochloride |
0054-0284 | Oxymorphone Hydrochloride | oxymorphone hydrochloride |
0115-1231 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1232 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1233 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1234 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1315 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1316 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
0115-1317 | Oxymorphone hydrochloride | Oxymorphone hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OPANA 77471861 3553676 Dead/Cancelled |
Endo Pharmaceuticals Inc. 2008-05-12 |
OPANA 77471835 3585918 Dead/Cancelled |
Endo Pharmaceuticals Inc. 2008-05-12 |
OPANA 76665614 3252736 Dead/Cancelled |
Endo Pharmaceuticals Inc. 2006-09-05 |
OPANA 76478457 3060635 Live/Registered |
Endo Pharmaceuticals Inc. 2002-12-20 |